Literature DB >> 11778970

Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia.

M Soker1, L Colpan, A Ece, C Devecioğlu, K Haspolat.   

Abstract

Serum levels of interleukin-1 beta (IL-1beta), soluble interleukin 2 receptors (sIL-2R), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha) were measured to predict some characteristics of febrile episodes in children with cancer and neutropenia. Forty-eight episodes of febrile neutropenia were determined in 23 pediatric cancer patients, including 35 febrile episodes without identifiable source, 7 episodes of bacteremia due to Gram-negative organisms and 4 due to Gram-positive organisms, and 2 fungal infections. Interleukin-6, sIL-2R, and IL-8 levels were significantly higher at the beginning of the febrile episodes than those of controls (p < 0.001, p < 0.001, and p < 0.001). Interleukin-6, slL-2R, and IL-8 levels were higher in patients with bacteremia due to Gram-negative organisms than in those with Gram-positive ones (p = 0.042, p = 0.006, and p = 0.023, respectively). TNF-alpha and IL-1beta levels were similar in febrile episodes and controls (p > 0.05). In conclusion, sIL-2R, IL-6, and IL-8 levels may be helpful in the prediction of infection in febrile cancer patients with neutropenia and measurements of IL-1beta and TNF-alpha were not useful for identifying the presence and the type of infection in febrile neutropenic episodes in children.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11778970     DOI: 10.1385/MO:18:1:51

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  16 in total

Review 1.  Therapy-induced alterations in host defense in children receiving therapy for cancer.

Authors:  T Lehrnbecher; C Foster; N Vázquez; C L Mackall; S J Chanock
Journal:  J Pediatr Hematol Oncol       Date:  1997 Sep-Oct       Impact factor: 1.289

Review 2.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

Review 3.  Management of fever in patients with cancer and treatment-induced neutropenia.

Authors:  P A Pizzo
Journal:  N Engl J Med       Date:  1993-05-06       Impact factor: 91.245

4.  Lymphocyte depletion during treatment with intensive chemotherapy for cancer.

Authors:  C L Mackall; T A Fleisher; M R Brown; I T Magrath; A T Shad; M E Horowitz; L H Wexler; M A Adde; L L McClure; R E Gress
Journal:  Blood       Date:  1994-10-01       Impact factor: 22.113

Review 5.  Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.

Authors:  R R Schumann
Journal:  Res Immunol       Date:  1992-01

Review 6.  Cytokine mediators of septic infections in the normal and granulocytopenic host.

Authors:  A Waage; S Steinshamn
Journal:  Eur J Haematol       Date:  1993-05       Impact factor: 2.997

7.  Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia.

Authors:  A Engel; W V Kern; G Mürdter; P Kern
Journal:  Infection       Date:  1994 May-Jun       Impact factor: 3.553

8.  Clinical significance of serum cytokine patterns during start of fever in patients with neutropenia.

Authors:  P Engervall; B Andersson; M Björkholm
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

9.  Interleukin 8 in serum in granulocytopenic patients with infections.

Authors:  A Waage; D Remick; S Steinshamn; L Deforge; J Lamvik
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

10.  T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.

Authors:  T Miethke; C Wahl; K Heeg; B Echtenacher; P H Krammer; H Wagner
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more
  8 in total

1.  Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.

Authors:  Januario E Castro; Johanna Melo-Cardenas; Mauricio Urquiza; Juan S Barajas-Gamboa; Ramin S Pakbaz; Thomas J Kipps
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

2.  Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.

Authors:  Rodolfo Rivas-Ruiz; Miguel Villasis-Keever; Guadalupe Miranda-Novales; Osvaldo D Castelán-Martínez; Silvia Rivas-Contreras
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

3.  Circulating inflammatory mediators during start of fever in differential diagnosis of gram-negative and gram-positive infections in leukopenic rats.

Authors:  Eva Tavares; Rosario Maldonado; Maria L Ojeda; Francisco J Miñano
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

4.  Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock.

Authors:  Xiao-Jun Xu; Yong-Min Tang; Chan Liao; Hua Song; Shi-Long Yang; Wei-Qun Xu; Shu-Wen Shi; Ning Zhao
Journal:  Intensive Care Med       Date:  2012-11-21       Impact factor: 17.440

5.  Biomarkers for Diagnosing Febrile Illness in Immunocompromised Children: A Systematic Review of the Literature.

Authors:  Fabian J S van der Velden; Andrew R Gennery; Marieke Emonts
Journal:  Front Pediatr       Date:  2022-03-10       Impact factor: 3.418

Review 6.  Predicting infectious complications in neutropenic children and young people with cancer (IPD protocol).

Authors:  Robert S Phillips; Alex J Sutton; Richard D Riley; Julia C Chisholm; Susan V Picton; Lesley A Stewart
Journal:  Syst Rev       Date:  2012-02-09

7.  Effect of allogeneic blood transfusion on levels of IL-6 and sIL-R2 in peripheral blood of children with acute lymphocytic leukemia.

Authors:  Hui Zhao; Huayou Zhou; Qiong Cao; Chunyan Wang; Jing Bai; Piao Lv; Fang Zhao
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

8.  Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.

Authors:  Hilde T van der Galiën; Erik A H Loeffen; Karin G E Miedema; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2018-05-19       Impact factor: 3.603

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.